Related Experiment Video
Updated: Aug 18, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Gilberta Giacchetti1, Leonardo A Sechi, Silvia Rilli
1The Division of Endocrinology, Department of Internal Medicine, Universita Politecnica della Marche, 60020 Ancona, Italy.
Abstract:
In diabetes mellitus (DM), the circulating renin-angiotensin system (RAS) is suppressed, but the renal tissue RAS is activated. Hyperglycemia increases tissue angiotensin II (Ang II), which induces oxidative stress, endothelial damage and disease pathology including vasoconstriction, thrombosis, inflammation and vascular remodeling. In early DM, the type 1 Ang II (AT(1)) receptor is upregulated but the type 2 Ang II (AT(2)) receptor is downregulated. This imbalance can predispose the individual to tissue damage. Hyperglycemia also increases the production of aldosterone, which has an unknown contribution to tissue damage. The insulin resistance state is associated with upregulation of the AT(1) receptor and an increase in oxygen free radicals in endothelial tissue caused by activation of NAD(P)H oxidase. Treatment with an AT(1) receptor blocker normalizes oxidase activity and improves endothelial function. An understanding of the tissue renin-angiotensin-aldosterone system, which is a crucial factor in the progression of tissue damage in DM, is imperative for protection against tissue damage in this chronic disease.
Insights
In diabetes mellitus, activated renal renin-angiotensin system (RAS) causes tissue damage. Blocking the Angiotensin II type 1 receptor (AT(1)) improves endothelial function and protects against diabetic complications.
Area of Science:
- Endocrinology
- Cardiovascular Research
- Nephrology
Background:
- Diabetes mellitus (DM) involves suppressed circulating renin-angiotensin system (RAS) but activated renal RAS.
- Hyperglycemia in DM elevates tissue angiotensin II (Ang II), leading to oxidative stress and endothelial damage.
- Early DM shows AT(1) receptor upregulation and AT(2) receptor downregulation, contributing to tissue injury.
Purpose of the Study:
- To investigate the role of the tissue renin-angiotensin-aldosterone system (RAAS) in diabetic tissue damage.
- To understand the impact of hyperglycemia on Ang II levels and receptor expression in DM.
- To evaluate the therapeutic potential of AT(1) receptor blockers in mitigating DM-related tissue pathology.
Main Methods:
- Analysis of circulating and tissue RAS components in diabetic models.
- Assessment of Ang II, aldosterone, and oxidative stress markers.
- Evaluation of AT(1) and AT(2) receptor expression patterns.
- Investigating the effects of AT(1) receptor blockers on endothelial function and NAD(P)H oxidase activity.
Main Results:
- Hyperglycemia-induced Ang II activation of AT(1) receptors drives oxidative stress and endothelial damage.
- Imbalance in AT(1)/AT(2) receptor expression is linked to diabetic tissue pathology.
- Insulin resistance exacerbates endothelial dysfunction via NAD(P)H oxidase activation.
- AT(1) receptor blockade normalizes oxidase activity and enhances endothelial function.
Conclusions:
- The tissue RAAS is a critical mediator of diabetic tissue damage.
- Targeting the AT(1) receptor offers a promising strategy for protecting against diabetic complications.
- Understanding the RAAS in DM is essential for developing effective therapeutic interventions.
Related Concept Videos
Hormonal Regulation
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
